Female Genital Fistula
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
2 programsAdverse Outcomes Following Female Genital Fistula RepairN/A1 trial
Multi-component reintegration interventionN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Human BioSciencesAdverse Outcomes Following Female Genital Fistula Repair
Human BioSciencesMulti-component reintegration intervention
Clinical Trials (2)
Total enrollment: 814 patients across 2 trials
Adverse Outcomes Following Female Genital Fistula Repair
Start: May 2022Est. completion: Jul 2026802 patients
N/AActive Not Recruiting
Fistula Reintegration Pilot
Start: Aug 2021Est. completion: Sep 202212 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.